With semaglutide (Wegovy, Ozempic), patients lose an average of 10-15% of body weight (25-37 pounds for a 250-pound person) over 16-18 months
These cases often involve claimants who lost their life savings or went into bankruptcy after years of losing money through deceptive risk-free promotions, constant app notifications, and aggressive marketing designed to keep them engaged
Zepbound beats Wegovy with 20.2% vs 13.7% body weight loss in the first-ever head-to-head trial (SURMOUNT-5), published in the New England Journal of Medicine
The Connection Between Epitalon and Telomeres Telomeres act like protective caps on chromosomes
References: Iossa S, Mollica MP, Lionetti L, et al
At DrJamesGlutathione, we believe that everyone deserves access to high-quality personal care products